Abstract:Introduction Post-traumatic stress disorder (PTSD) is defined by an exaggerated fear responses (FA) which fails to extinguish over time and cannot be inhibited in safe contexts. Studies report that traumatic experiences (TE) affect hormonal systems mediated by the hypothalamic-pituitary-adrenal (HPA) axis and the oxytocinergic system. Oxytocin (OXT) is a neurohormone produced in the hypothalamus that has social functions like the promotion of prosocial and affiliative behaviors, increased self-confidence and positive social memories. In PTSD there is a diminished inhibitory top-down control over the FA, which is characterized by amygdala hyperactivity, ventromedial prefrontal cortex (vmPFC) hypoactivity and diminished structural and functional connectivity between both areas, which results in anxiety increase and dysregulated autonomic and endocrine FA. In parallel, TE decrease the synthesis and release of OXT, resulting in the dysfunction of the negative feedback mechanism on the HPA, leading to hypercortisolemia and maximizing the response to a stressful stimulus. Previous studies report that the administration of OXT can reduce cortisol levels as well as attenuating amygdala hyperactivity and normalizing the connectivity of this structure with frontal areas, diminishing the FA. Therefore, OXT has been investigated as a potential therapeutic agent administered intranasally early after trauma as a strategy to prevent PTDS on individuals having high risk. Objectives The aim of this work is to review the potential of intranasal OXT administration as early preventive intervention for PTSD. Methods Systematic review of the literature published in Pubmed, using the terms "Oxytocin", "Post-traumatic Stress Disorder", "Stress". Results Studies found significant associations between TE and OXT and report that TE and PTSD are strongly associated with reductions in OXT. Literature report that the acute effects of OXT administrations in individuals with TE tend to be anxiolytic only in less severe forms, by modulating the HPA axis and the autonomic nervous system. Moreover, in recent TE, OXT seems to increase the re-experience of traumas and restore the function of different networks associated with fear control in PTSD patients. FMRI studies indicate that intranasal OXT attenuates amygdala hyperactivity and enhances amygdala ́s connectivity with vmPFC, resulting in increased control over the FA. Finally, studies report that a single oxytocin administration increases neuronal fear processing but repeated administration reduces PTSD symptoms up to 6 months post trauma in patients with high acute symptoms. Conclusions Repeated administration of intranasal oxytocin early after trauma seems to diminish the acute symptoms in early stages of PTDS, being a potential pharmacological strategy to prevent PTDS in individuals at high risk by increasing the control of FA. Disclosure of Interest None Declared

Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders

Oxytocin System in Neuropsychiatric Disorders: Old Concept, New Insights.

Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders.

Oxytocinergic Modulation of Stress-Associated Amygdala-Hippocampus Pathways in Humans Is Mediated by Serotonergic Mechanisms

Oxytocin: An Old Hormone, A Novel Psychotropic Drug And Possible Use In Treating Psychiatric Disorders.

The Role of Oxytocin in Early-Life-Stress-Related Neuropsychiatric Disorders

Brain oxytocin: how puzzle stones from animal studies translate into psychiatry

The association of oxytocin with major depressive disorder: role of confounding effects of antidepressants

Effects of Oxytocin on Fear Memory and Neuroinflammation in a Rodent Model of Posttraumatic Stress Disorder

The Potential Use Of Intranasal Oxytocin As Early Preventive Intervention For Post-Traumatic Stress Disorder

Roles of Oxytocin in Stress Responses, Allostasis and Resilience

The interaction of oxytocin and nicotine addiction on psychosocial stress: an fMRI study

Oxytocin: An expansive review of its mechanisms, functions, and therapeutic potential

Can oxytocin inhibit stress-induced hyperalgesia?

Overview of Human Oxytocin Research

Oxytocin Protects Against Corticosterone-Induced DA Dysfunction: An Involvement of the PKA/CREB Pathway

Intrinsic, Dynamic and Effective Connectivity among Large-Scale Brain Networks Modulated by Oxytocin

Oxytocin and brain activity in humans: A systematic review and coordinate-based meta-analysis of functional MRI studies

Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin

Oxytocin in health and disease

Oxytocin Treatments or Activation of the Paraventricular Nucleus-the Shell of Nucleus Accumbens Pathway Reduce Adverse Effects of Chronic Social Defeat Stress on Emotional and Social Behaviors in Mandarin Voles.